Providers Embrace US FDA REMS Integration Plan But Wary Of Another iPledge ‘Failure’

risk mitigation
Patients and providers stressed that back-up plans be in place when the new REMS integration software is tested. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet